[Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)]. / Le peptide intestinal vasoactif (VIP) au cours du syndrome de Verner-Morrison.
Nouv Presse Med
; 8(18): 1505-8, 1979 Apr 21.
Article
em Fr
| MEDLINE
| ID: mdl-224378
ABSTRACT
An early diagnosis of the Verner-Morrison syndrome will greatly enhance the chances of curative resection. There is a striking need for a simple diagnostic test. A number of suggestions have been made for the presumed hormone mediator of this syndrome. Numerous reports have led to a wide acceptance that vasoactive intestinal peptide (VIP) is the responsible mediator for the pharmacologic actions of this peptide are similar to the physiological characteristics noted in the watery diarrhea syndrome. A raised plasma VIP concentration, on the other hand, would suggest the presence of a tumour. These observations argue for the radioimmunoassay measurement of plasma VIP in a patient with the watery diarrhea syndrome.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Peptídeo Intestinal Vasoativo
/
Diarreia
/
Hormônios Gastrointestinais
/
Hipopotassemia
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Limite:
Humans
Idioma:
Fr
Revista:
Nouv Presse Med
Ano de publicação:
1979
Tipo de documento:
Article